Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
145.55
+4.48 (3.18%)
At close: Jan 12, 2026, 4:00 PM EST
144.60
-0.95 (-0.65%)
After-hours: Jan 12, 2026, 7:57 PM EST
Illumina Employees
Illumina had 10,370 employees as of December 31, 2024. The number of employees decreased by 2,020 or -16.30% compared to the previous year.
Employees
10,370
Change (1Y)
-2,020
Growth (1Y)
-16.30%
Revenue / Employee
$413,500
Profits / Employee
$67,792
Market Cap
22.24B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
| Dec 31, 2023 | 12,390 | -970 | -7.26% |
| Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
| Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
| Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
| Dec 29, 2019 | 7,700 | 400 | 5.48% |
| Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
| Dec 31, 2017 | 6,200 | 700 | 12.73% |
| Dec 31, 2016 | 5,500 | 900 | 19.57% |
| Dec 31, 2015 | 4,600 | 900 | 24.32% |
| Dec 28, 2014 | 3,700 | 700 | 23.33% |
| Dec 29, 2013 | 3,000 | 800 | 36.36% |
| Dec 31, 2012 | 2,200 | -200 | -8.33% |
| Dec 30, 2012 | 2,400 | 300 | 14.29% |
| Dec 31, 2011 | 2,100 | 319 | 17.91% |
| Dec 31, 2010 | 1,781 | 245 | 15.95% |
| Dec 28, 2008 | 1,536 | 495 | 47.55% |
| Dec 30, 2007 | 1,041 | 445 | 74.66% |
| Dec 31, 2006 | 596 | 221 | 58.93% |
| Dec 31, 2005 | 375 | 97 | 34.89% |
| Dec 31, 2004 | 278 | 42 | 17.80% |
| Dec 28, 2003 | 236 | 3 | 1.29% |
| Dec 29, 2002 | 233 | 54 | 30.17% |
| Dec 30, 2001 | 179 | 74 | 70.48% |
| Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ILMN News
- 6 hours ago - Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 - PRNewsWire
- 4 days ago - Illumina Appoints Dr. Eric Green as Chief Medical Officer - PRNewsWire
- 4 days ago - Illumina and PREMIA partner to expand clinical access to CGP in Asia - GlobeNewsWire
- 6 days ago - Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - PRNewsWire
- 27 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 27 days ago - Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors - Benzinga
- 4 weeks ago - Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PRNewsWire
- 7 weeks ago - Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha